Vantage Consulting Group’s Surmodics SRDX Stock Holding History

Vantage Consulting Group’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-324	Closed	-$14K	–	1363
2020 Q4	$14K	Buy	+324	New	+$12.8K	﹤0.01%	1049

Other funds holding SRDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vantage Consulting Group's SRDX Position: Q1 2021 in Review

Vantage Consulting Group sold out of Surmodics (SRDX) in Q1 2021, closing a stake of 324 shares — an estimated $14K sold.

Vantage Consulting Group first reported a position in SRDX in Q4 2020 and held it in 1 quarter. The position peaked at $14K in Q4 2020. 138 funds tracked by Wall St. Rank hold SRDX as of Q1 2021.

Vantage Consulting Group reported no remaining Surmodics position as of Q1 2021 after selling out during the quarter.
Vantage Consulting Group sold 324 Surmodics shares in Q1 2021, an estimated $14K.
Vantage Consulting Group first reported a position in Surmodics in Q4 2020 and held it in 1 quarter.
Vantage Consulting Group's Surmodics position peaked at $14K in Q4 2020.
138 funds tracked by Wall St. Rank held Surmodics as of Q1 2021.

Based on Vantage Consulting Group's 13F filing for Q1 2021, filed 14 May 2021.